Targeted Molecular Imaging Using Aptamers in Cancer

Area of Science:

• Biomedical Imaging
• Molecular Biology
• Nanotechnology

Background:

• Nucleic acid aptamers offer superior molecular recognition and cellular uptake for targeted imaging.
• Recent advancements have expanded aptamer applications across various imaging modalities.
• Aptamers are versatile tools for both intracellular and in vivo imaging.

Purpose of the Study:

• To review the evolving applications of aptamers in diverse imaging fields.
• To highlight the transformative impact of aptamers on cellular and clinical imaging.
• To showcase aptamer-based strategies for cancer detection and research.

Main Methods:

• Development of genetically encoded biosensors with fluorescent RNA aptamers for intracellular imaging.
• Labeling cancer-specific aptamers with fluorescence for clinical tissue specimen assessment.
• Conjugation of aptamers with gold nanoparticles for mass spectrometry tissue imaging.
• Chemical conjugation of cancer-specific aptamers as probes for in vivo imaging.

Main Results:

• Genetically encoded aptamer biosensors enable live-cell imaging of cellular signaling and physiology.
• Fluorescently labeled cancer aptamers facilitate accurate assessment of clinical tissue samples.
• Aptamer-gold nanoparticle conjugates advance mass spectrometry-based tissue imaging.
• Chemically conjugated aptamers provide high-resolution, non-invasive in vivo cancer imaging.

Conclusions:

• Nucleic acid aptamers are a transformative technology in targeted molecular imaging.
• Aptamers facilitate diverse imaging applications, from live cells to in vivo cancer detection.
• The versatility of aptamers promises continued innovation in biomedical imaging and diagnostics.